NEW YORK, Aug. 4, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CCXI, NVIV, GRNA, MF, and NNVC.

InvestorsObserver (PRNewsfoto/InvestorsObserver)

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

  • CCXI: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=CCXI&prnumber=080420222
  • NVIV: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=NVIV&prnumber=080420222
  • GRNA: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=GRNA&prnumber=080420222
  • MF: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=MF&prnumber=080420222
  • NNVC: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=NNVC&prnumber=080420222

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-chemocentryx-invivo-therapeutics-greenlight-biosciences-missfresh-or-nanoviricides-301600088.html

SOURCE InvestorsObserver